GoodRx Holdings, Inc. (GDRX) Tops Q4 EPS by 1c, Offers Guidance

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q4 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $153.5 million versus the consensus estimate of $147.8 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q1 2021 revenue of $158-161 million, versus the consensus of $162 million.

GoodRx Holdings, Inc. sees FY2021 revenue of $735-755 million, versus the consensus of $737.6 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c